SCHEMBL30847966

SCHEMBL30847966

Cn1ccc2cccc(N)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 1/20 0.39
▸ CYP3A4 P08684 4/20 0.38
▸ TSHR P16473 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ KEAP1 Q14145 1/20 0.38
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CB P42338 1/20 0.36
▸ CMA1 P23946 1/20 0.35
▸ HTR3A P46098 1/20 0.34
▸ CD44 P16070 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ PTPN11 Q06124 1/20 0.33
▸ ALOX15 P16050 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HTR2A P28223 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4387353 1.00 PRKCI (0.39) PRKCICYP3A4TSHRALDH1A1HPGD
SCHEMBL13836115 0.76 PSMD14 (0.37) PRKCICMA1PTPN11HTR2AHTR2C
SCHEMBL30109166 0.76 MEN1 (0.41) ALDH1A1CMA1PTPN11
SCHEMBL436336 0.76 MEN1 (0.41) ALDH1A1CMA1PTPN11
SCHEMBL4951560 0.76 CYP3A4 (0.39) CYP3A4TSHRALDH1A1HPGDHSD17B10
SCHEMBL2625811 0.74 CDK4 (0.41) PRKCICMA1
SCHEMBL29989147 0.74 CDK4 (0.41) PRKCICMA1
SCHEMBL2052186 0.74 CYP1A2 (0.38) ALDH1A1HPGDHSD17B10CMA1MAPT
SCHEMBL2178459 0.74 CDK4 (0.43) PRKCIALDH1A1CMA1PTPN11
SCHEMBL4953962 0.74 CYP3A4 (0.38) CYP3A4TSHRALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback